亨廷顿病中与丁苯那嗪相关的迟发性综合征：一例报告 - Suppr

Suppr

超能文献

Tardive Syndrome Associated With Tetrabenazine in Huntington Disease: A Case Report.

作者信息

Palermo Giovanni, Mazzucchi Sonia, Unti Elisa, Bonuccelli Ubaldo, Ceravolo Roberto

出版信息

J Clin Psychopharmacol. 2020 Nov/Dec;40(6):628-630. doi: 10.1097/JCP.0000000000001295.

DOI:10.1097/JCP.0000000000001295

PMID:33136925

Abstract

摘要

相似文献

Tardive Syndrome Associated With Tetrabenazine in Huntington Disease: A Case Report.

J Clin Psychopharmacol. 2020 Nov/Dec;40(6):628-630. doi: 10.1097/JCP.0000000000001295.

Deutetrabenazine (Austedo) for Huntington's chorea and tardive dyskinesia.

Med Lett Drugs Ther. 2018 Apr 23;60(1545):65-68.

Deutetrabenazine: Treatment of hyperkinetic aspects of Huntington's disease, tardive dyskinesia and Tourette syndrome.

Drugs Today (Barc). 2017 Feb;53(2):89-102. doi: 10.1358/dot.2017.53.2.2589164.

Deutetrabenazine in the treatment of tardive dyskinesia.

Neurodegener Dis Manag. 2019 Apr;9(2):59-71. doi: 10.2217/nmt-2018-0042. Epub 2019 Jan 31.

[Tetrabenazine (tetrabenazine Orphan) orally].

J Pharm Belg. 2014 Dec(4):49-50.

Deuterium Tetrabenazine for Tardive Dyskinesia.

Clin Schizophr Relat Psychoses. 2018 Jan;11(4):214-220. doi: 10.3371/CSRP.CUPR.010318.

Treatment of tardive dyskinesia with tetrabenazine or valbenazine: a systematic review.

J Comp Eff Res. 2018 Feb;7(2):135-148. doi: 10.2217/cer-2017-0065. Epub 2017 Oct 2.

Tetrabenazine, depression and suicide: good news.

J Huntingtons Dis. 2014;3(2):137-8. doi: 10.3233/JHD-140107.

Tetrabenazine and suicidal ideation.

J Neuropsychiatry Clin Neurosci. 2013 Winter;25(1):E30. doi: 10.1176/appi.neuropsych.12020033.

[Pharmacological properties and clinical efficacy of tetrabenazine (Choreazine(®)Tablets 12.5 mg), a therapeutic agent for non-rhythmic involuntary movement].

Nihon Yakurigaku Zasshi. 2014 Mar;143(3):144-51. doi: 10.1254/fpj.143.144.

引用本文的文献

Meta-analysis and systematic review of vesicular monoamine transporter (VMAT-2) inhibitors in schizophrenia and psychosis.

Psychopharmacology (Berl). 2024 Feb;241(2):225-241. doi: 10.1007/s00213-023-06488-3. Epub 2024 Jan 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Tardive Syndrome Associated With Tetrabenazine in Huntington Disease: A Case Report.

J Clin Psychopharmacol. 2020 Nov/Dec;40(6):628-630. doi: 10.1097/JCP.0000000000001295.

Deutetrabenazine (Austedo) for Huntington's chorea and tardive dyskinesia.

Med Lett Drugs Ther. 2018 Apr 23;60(1545):65-68.

Deutetrabenazine: Treatment of hyperkinetic aspects of Huntington's disease, tardive dyskinesia and Tourette syndrome.

Drugs Today (Barc). 2017 Feb;53(2):89-102. doi: 10.1358/dot.2017.53.2.2589164.

Deutetrabenazine in the treatment of tardive dyskinesia.

Neurodegener Dis Manag. 2019 Apr;9(2):59-71. doi: 10.2217/nmt-2018-0042. Epub 2019 Jan 31.

[Tetrabenazine (tetrabenazine Orphan) orally].

J Pharm Belg. 2014 Dec(4):49-50.

Deuterium Tetrabenazine for Tardive Dyskinesia.

Clin Schizophr Relat Psychoses. 2018 Jan;11(4):214-220. doi: 10.3371/CSRP.CUPR.010318.

Treatment of tardive dyskinesia with tetrabenazine or valbenazine: a systematic review.

J Comp Eff Res. 2018 Feb;7(2):135-148. doi: 10.2217/cer-2017-0065. Epub 2017 Oct 2.

Tetrabenazine, depression and suicide: good news.

J Huntingtons Dis. 2014;3(2):137-8. doi: 10.3233/JHD-140107.

Tetrabenazine and suicidal ideation.

J Neuropsychiatry Clin Neurosci. 2013 Winter;25(1):E30. doi: 10.1176/appi.neuropsych.12020033.

[Pharmacological properties and clinical efficacy of tetrabenazine (Choreazine(®)Tablets 12.5 mg), a therapeutic agent for non-rhythmic involuntary movement].

Nihon Yakurigaku Zasshi. 2014 Mar;143(3):144-51. doi: 10.1254/fpj.143.144.

引用本文的文献

Meta-analysis and systematic review of vesicular monoamine transporter (VMAT-2) inhibitors in schizophrenia and psychosis.

Psychopharmacology (Berl). 2024 Feb;241(2):225-241. doi: 10.1007/s00213-023-06488-3. Epub 2024 Jan 19.